Sorafenib is an important first-line treatment option for liver cancer due to its well-
characterized safety profile. While novel first-line drugs may have better efficacy than …

Ferroptosis, an emerging type of programmed cell death, is initiated by iron-dependent and
excessive ROS-mediated lipid peroxidation, which eventually leads to plasma membrane …

The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) represents the
master regulator of the cellular antioxidant response and plays a critical role in …

Ferroptosis is an emerging type of regulated cell death usually accompanied by the
accumulation of ferrous ions (Fe2+) and lipid peroxides. As the metabolic hub of the body …

Hepatocellular carcinoma (HCC) is the sixed most common malignant tumor in the world.
The study for HCC is mired in the predicament confronted with the difficulty of early …

Alkaloids have remarkable biological and pharmacological properties and have recently
garnered extensive attention. Various alkaloids, including commercially available drugs …

Hepatocellular carcinoma (HCC) is the predominant form of liver cancer and ranks as the
third leading cause of cancer-related mortality globally. The liver performs a wide range of …

Exploring novel early detection biomarkers and develo** more efficacious treatments
remain pressing tasks in the current research landscape for hepatocellular carcinoma …

Polypharmacy is commonly employed in clinical settings. The potential risks of drug–drug
interactions (DDIs) can compromise efficacy and pose serious health hazards. Integrating …

Abstract Introduction and Objectives We initiated this study to explore the efficacy of
camrelizumab combined with transcatheter arterial chemoembolization (TACE) plus …